aurora12.JPG
Aurora Spine Corporation Announces Record First Quarter Fiscal 2022 Financial Results
24 mai 2022 07h15 HE | Aurora Spine Corporation
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:...
22157.jpg
Global Pharmaceuticals & Biotechnology Royalty Rates Report 2022 with Detailed Financial Information from Real-World Transactions
24 mai 2022 04h38 HE | Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition" report has been added to ResearchAndMarkets.com's offering. Royalty Rates for...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Appointment of William Heiden to Board of Directors
23 mai 2022 16h01 HE | MacroGenics, Inc.
ROCKVILLE, MD, May 23, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the...
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics Announces Data From REDWOOD-HCM OLE and GALACTIC-HF Presented as Late Breaking Science Presentations at the European Society of Cardiology Heart Failure 2022 Congress
23 mai 2022 11h30 HE | Cytokinetics, Incorporated
Data from Up to Six Months of Treatment with Aficamten Show Significant and Sustained Reductions in LVOT Gradients with Improvements in Functional Class, Symptoms, and Biomarkers Analyses from...
Compass-logo-RGB-outlines.png
Compass Therapeutics to Present at the 2022 H.C. Wainwright Annual Global Investment Conference
23 mai 2022 08h00 HE | Compass Therapeutics
BOSTON, May 23, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...
AquaBounty_Blue_Flat_SPOT2995_FINAL.png
Proxy Advisory Firm ISS Recommends Vote “FOR” the Charter Amendment Proposal – To Increase the Number of Authorized Shares of Common Stock
20 mai 2022 16h05 HE | AquaBounty Technologies, Inc.
MAYNARD, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance...
aphex_email.png
Aphex BioCleanse Systems Inc Files for Bankruptcy Protection under Chapter 11, Subchapter V
19 mai 2022 09h45 HE | Aphex BioCleanse Systems, Inc
Venice, FL, May 19, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST), has filed a voluntary petition under the Federal Bankruptcy Code, Chapter 11, Subchapter V. The Petition...
ultragenyx-CMYK.png
Ultragenyx Announces Positive Longer-term Durability Data from Two Phase 1/2 Gene Therapy Studies at American Society of Gene & Cell Therapy (ASGCT) 2022 Annual Meeting
19 mai 2022 08h00 HE | Ultragenyx Pharmaceutical Inc.
Durable and clinically meaningful responses sustained for more than three years post-treatment in study of DTX401 for GSDIa and four or more years in study of DTX301 for OTC NOVATO, Calif., May ...
7 Hills Logo.png
New Study Demonstrates Integrin Activation Can Bring the Heat to Cold Melanoma Tumors
18 mai 2022 19h23 HE | 7 Hills Pharma
HOUSTON, May 18, 2022 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC (“7 Hills” or “7HP”), together with The University of Texas MD Anderson Cancer Center (“MD Anderson”) and Texas Heart Institute (“THI”),...
PDS Biotech Logo.png
PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development
18 mai 2022 08h00 HE | PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 18, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer...